FERRER INTERNACIONAL, S.A.;FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULA- RES CARLOS III
发明人:
MARTIN SANZ, Pablo,URBANO HURTADO, Javier
申请号：
GEAP2014014027
公开号：
GEP201706743B
申请日:
2014.06.05
申请国别(地区):
GE
年份:
2017
代理人:
摘要：
Peroral therapeutic agent, which is two independent dosage forms covered with a coat contains acetylsalicylic acid as first active agent and HMG-CoA reductase inhibitor as second active agent； at that, the coat of dosage form contains polymer soluble in water. Said therapeutic agent is used for the treatment of cardiovascular diseases.
